Nexletol is an innovative oral medication for treating hypercholesterolemia, which reduces LDL-C by inhibiting ATP citrate lyase. The standard ...
Nexletol is a novel oral cholesterol lowering drug, particularly suitable for patients with statin intolerance. As an ATP citrate lyase inhibit...
Nexletol is an oral medication used to treat hypercholesterolemia, which reduces low-density lipoprotein cholesterol (LDL-C) by inhibiting ATP ...
Saphnelo is an FDA approved type I interferon receptor antagonist for moderate to severe systemic lupus erythematosus (SLE), with a standard do...
Saphnelo, as a targeted biological agent for the treatment of moderate to severe systemic lupus erythematosus, requires special attention to in...
Saphnelo is an innovative biological agent targeting type I interferon receptors, specifically designed for the treatment of moderate to severe...
Saphnelo is a biological agent used for the treatment of systemic lupus erythematosus (SLE), administered via intravenous infusion. The standar...
Tenapanor, as a selective NHE3 inhibitor, is mainly used for the treatment of hyperphosphatemia in dialysis patients with chronic kidney diseas...
Tenapano tablets, as a novel sodium/hydrogen exchanger 3 (NHE3) inhibitor, effectively control hyperphosphatemia in dialysis patients by inhibi...
Xphozah is a phosphorus lowering drug used for the treatment of hyperphosphatemia in dialysis patients. It is necessary to strictly follow the ...